New Delhi, Nov. 7 -- Divi's Laboratories Ltd on Friday beat Street estimates to report a robust double-digit revenue and profit growth for July-September, the second quarter of this fiscal year.

The Hyderabad-based drugmaker's consolidated revenue from operations was up 17% from a year ago at Rs.2,860 crore. The contract manufacturer reported a consolidated net profit of Rs.689 crore, up 35% year-on-year (y-o-y). The company posted a foreign exchange gain of Rs.63 crore.

On a constant currency basis, the revenue growth was 10.8% for the quarter.

A Bloomberg poll had pegged the company's revenue at Rs.2,599 crore and profit after tax at Rs.608.9 crore. Analysts expected the company's revenue to grow 9-10% y-o-y, led by growth in its cus...